Estrella Immunopharma, Inc. (ESLA)
0.39
-0.02
(-4.90%)
USD |
NASDAQ |
Nov 06, 09:59
Estrella Immunopharma Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| March 28, 2025 | 232.07 |
| March 27, 2025 | 234.24 |
| March 26, 2025 | 246.83 |
| March 25, 2025 | 251.85 |
| March 24, 2025 | 249.30 |
| March 21, 2025 | 254.39 |
| March 20, 2025 | 232.15 |
| March 19, 2025 | 249.35 |
| March 18, 2025 | 229.20 |
| March 17, 2025 | 241.09 |
| March 14, 2025 | 231.72 |
| March 13, 2025 | 256.91 |
| March 12, 2025 | 256.91 |
| March 11, 2025 | 243.99 |
| March 10, 2025 | 226.68 |
| March 07, 2025 | 248.85 |
| March 06, 2025 | 249.35 |
| March 05, 2025 | 261.95 |
| March 04, 2025 | 256.91 |
| March 03, 2025 | 249.35 |
| February 28, 2025 | 259.43 |
| February 27, 2025 | 241.80 |
| February 26, 2025 | 277.06 |
| February 25, 2025 | 292.17 |
| February 24, 2025 | 332.47 |
| Date | Value |
|---|---|
| February 21, 2025 | 372.77 |
| February 20, 2025 | 375.29 |
| February 19, 2025 | 345.06 |
| February 18, 2025 | 362.69 |
| February 14, 2025 | 311.06 |
| February 13, 2025 | 284.61 |
| February 12, 2025 | 284.61 |
| February 11, 2025 | 287.13 |
| February 10, 2025 | 269.50 |
| February 07, 2025 | 282.10 |
| February 06, 2025 | 289.65 |
| February 05, 2025 | 275.80 |
| February 04, 2025 | 277.06 |
| February 03, 2025 | 277.06 |
| January 31, 2025 | 264.46 |
| January 30, 2025 | 282.10 |
| January 29, 2025 | 295.27 |
| January 28, 2025 | 279.58 |
| January 27, 2025 | 294.69 |
| January 24, 2025 | 284.61 |
| January 23, 2025 | 297.21 |
| January 22, 2025 | 287.13 |
| January 21, 2025 | 292.17 |
| January 17, 2025 | 297.21 |
| January 16, 2025 | 295.19 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.752 |
| Alnylam Pharmaceuticals, Inc. | 5.840 |
| Anika Therapeutics, Inc. | 1.652 |
| Savara, Inc. | 6.505 |
| Vericel Corp. | 7.046 |
Price to Book Value Related Metrics
| Price | 0.39 |
| Earnings Yield | -65.03% |
| Market Cap | 16.78M |